Patent protections in the biopharmaceutical industry are designed to foster early innovation while ultimately enabling robust market competition—but the balance is often misunderstood. By granting ...
A Blueprint for FDA: Recommendations to Improve Innovation and Access [1] (FDA Blueprint) is a timely white paper authored by University of Southern California scholars that identifies U.S. Food and ...
Pharmaceutical innovation saves lives. But not every “new” drug is truly new. Such practices raise concerns about drug access and affordability, especially when companies use minor tweaks to block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results